Estryx Pharma Limited
Records under this name other than patents Estryx Pharma Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 3 of 3 · Back to Estryx Pharma Limited
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,846,737 | Compound Lapsed on the fee record Ended Sep 30, 2026 · High confidence | Lapsed on the fee record | Ended Sep 30, 2026 | High confidence |
| US 9,682,941 | Substituted biphenyl analogues as dual inhibitors of aromatase and sulfatase Lapsed on the fee record Ended Jun 20, 2025 · From the USPTO record | Lapsed on the fee record | Ended Jun 20, 2025 | From the USPTO record |
| US 8,394,825 | Compound Lapsed on the fee record Ended Mar 12, 2017 · From the USPTO record | Lapsed on the fee record | Ended Mar 12, 2017 | From the USPTO record |